Centene Corporation (CNC) Earnings Call Transcripts

78 earnings calls from January 2020 to July 28, 2026

NYSE US Health Care Health Care Providers and Services

Centene Corporation's Latest Earnings Call - Q2 FY2026

In the second quarter of 2026, Centene Corporation reported strong financial results, with adjusted diluted earnings per share (EPS) of $2.51, exceeding expectations and driven by solid operational execution. Revenue reached $44.4 billion, reflecting a significant increase compared to prior guidance. Management raised its full-year EPS outlook to greater than $4.80, up from $3.40, indicating confidence in ongoing business momentum and improved margin forecasts across its segments, particularly in Marketplace and Medicare.

Reported metrics

MetricValueContext
Revenue $44.4B (beat) vs prior guidance, reflecting a $6B increase
Adjusted EPS $2.51 (beat) exceeded expectations, beat by $0.12
Medicaid Membership 12.1M (negative) down from expectations, with 8-9% decline projected
Marketplace Pretax Margin 4.5%-5% (positive) up from previous guidance of 3%
Medicare Pretax Margin >3% (positive) improved from initial guidance of 2%
SG&A Expense Ratio 6.9% (positive) down from 7.1% year-over-year

Guidance from management

Centene now expects full-year adjusted EPS to exceed $4.80, significantly raised from prior guidance of $3.40, driven by strong performance in Marketplace and Medicare segments. Membership attrition in Medicaid is anticipated to be higher than previously estimated, impacting future guidance.

What management said

Yes, Justin, so you're right, the $481 million is in the Q. That's an absolute number. And then you may recall, every year we have explicit margin on these estimates that gets released and then reestablished largely the same amount. So that's about $250 million, that doesn't benefit the P&L relative to our prior guidance because that's expected to roll each year. And so that gets you down to about $230 million. And t...
— Andrew Asher, Q2 FY2026 earnings call
Kevin, on your last point, do you mean relative to those 2 dropped during redeterminations or those who have already rolled off in some of the sort of early attrition, if you will?
— Sarah London, Q2 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns over Medicaid membership attrition and its potential impact on future margins. Questions were raised about the acuity of the remaining membership and how upcoming regulatory changes might affect profitability.

Main topics on the call

Read the full Centene Corporation transcript (Q2 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Centene Corporation

Centene Corporation (CNC) is a publicly listed company in the Health Care Providers and Services industry, within the Health Care sector. It trades on NYSE and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 78 calls on record spanning January 13, 2020 to July 28, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 78 Centene Corporation earnings call transcripts on record, spanning January 13, 2020 to July 28, 2026. Based on this history, Centene Corporation reports quarterly. The most recent call on file is dated July 28, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
CNC
Exchange
NYSE
Country
US
Sector
Health Care
Industry
Health Care Providers and Services
Calls on record
78
First call
January 13, 2020
Most recent
July 28, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 Jul 28, 2026 Read transcript
Q1 FY2026 Apr 28, 2026 Read transcript
Special Calls Apr 17, 2026 Read transcript
Earnings Calls Apr 13, 2026 Read transcript
Company Conference Presentations Mar 10, 2026 Read transcript
Q4 FY2025 Feb 6, 2026 Read transcript
Company Conference Presentations Nov 11, 2025 Read transcript
Q3 FY2025 Oct 29, 2025 Read transcript
Company Conference Presentations Sep 11, 2025 Read transcript
Q2 FY2025 Jul 25, 2025 Read transcript
Q1 FY2025 Apr 25, 2025 Read transcript
Special Calls Apr 17, 2025 Read transcript
Company Conference Presentations Mar 12, 2025 Read transcript
Q4 FY2024 Feb 4, 2025 Read transcript
Analyst/Investor Day Dec 12, 2024 Read transcript
Q3 FY2024 Oct 25, 2024 Read transcript
Company Conference Presentations Sep 18, 2024 Read transcript
Company Conference Presentations Sep 4, 2024 Read transcript
Q2 FY2024 Jul 26, 2024 Read transcript
Company Conference Presentations May 31, 2024 Read transcript
Q1 FY2024 Apr 26, 2024 Read transcript
Company Conference Presentations Mar 12, 2024 Read transcript
Earnings Calls Feb 6, 2024 Read transcript
Company Conference Presentations Jan 9, 2024 Read transcript
Analyst/Investor Day Dec 12, 2023 Read transcript
Q3 FY2023 Oct 24, 2023 Read transcript
Company Conference Presentations Sep 13, 2023 Read transcript
Company Conference Presentations Sep 6, 2023 Read transcript
Q2 FY2023 Jul 28, 2023 Read transcript
Company Conference Presentations Jun 1, 2023 Read transcript
Q1 FY2023 Apr 25, 2023 Read transcript
Company Conference Presentations Mar 14, 2023 Read transcript
Q4 FY2022 Feb 7, 2023 Read transcript
Company Conference Presentations Jan 9, 2023 Read transcript
Analyst/Investor Day Dec 16, 2022 Read transcript
Company Conference Presentations Nov 8, 2022 Read transcript
Q3 FY2022 Oct 25, 2022 Read transcript
Company Conference Presentations Sep 13, 2022 Read transcript
Q2 FY2022 Jul 26, 2022 Read transcript
Special Calls Jun 17, 2022 Read transcript
Company Conference Presentations May 10, 2022 Read transcript
Shareholder/Analyst Calls Apr 26, 2022 Read transcript
Q1 FY2022 Apr 26, 2022 Read transcript
Company Conference Presentations Mar 15, 2022 Read transcript
Earnings Calls Feb 8, 2022 Read transcript
Company Conference Presentations Jan 10, 2022 Read transcript
Analyst/Investor Day Dec 10, 2021 Read transcript
Company Conference Presentations Nov 17, 2021 Read transcript
Company Conference Presentations Nov 10, 2021 Read transcript
Company Conference Presentations Nov 3, 2021 Read transcript
Q3 FY2021 Oct 26, 2021 Read transcript
Company Conference Presentations Sep 13, 2021 Read transcript
Q2 FY2021 Jul 27, 2021 Read transcript
Analyst/Investor Day Jun 16, 2021 Read transcript
Company Conference Presentations Jun 3, 2021 Read transcript
Company Conference Presentations May 12, 2021 Read transcript
Shareholder/Analyst Calls Apr 27, 2021 Read transcript
Q1 FY2021 Apr 27, 2021 Read transcript
Company Conference Presentations Mar 16, 2021 Read transcript
Company Conference Presentations Mar 9, 2021 Read transcript
Earnings Calls Feb 9, 2021 Read transcript
Company Conference Presentations Jan 11, 2021 Read transcript
M&A Calls Jan 4, 2021 Read transcript
Analyst/Investor Day Dec 18, 2020 Read transcript
Company Conference Presentations Nov 16, 2020 Read transcript
Company Conference Presentations Nov 10, 2020 Read transcript
Q3 FY2020 Oct 27, 2020 Read transcript
Company Conference Presentations Sep 14, 2020 Read transcript
Q2 FY2020 Jul 28, 2020 Read transcript
Company Conference Presentations Jun 23, 2020 Read transcript
Analyst/Investor Day Jun 12, 2020 Read transcript
Company Conference Presentations May 13, 2020 Read transcript
Shareholder/Analyst Calls Apr 28, 2020 Read transcript
Q1 FY2020 Apr 28, 2020 Read transcript
Company Conference Presentations Mar 10, 2020 Read transcript
Guidance/Update Calls Mar 4, 2020 Read transcript
Q4 FY2019 Feb 4, 2020 Read transcript
Company Conference Presentations Jan 13, 2020 Read transcript